| Year |
Title |
Altmetric |
| 2019
|
Genetic defects in mitochondrial dynamics in caenorhabditis elegans impact ultraviolet c radiation- and 6-hydroxydopamine-induced neurodegeneration.
International Journal of Molecular Sciences.
20.
2019
|
|
| 2019
|
Found in translation: The utility of C. elegans Alpha-Synuclein models of Parkinson’s disease.
Brain Sciences.
9.
2019
|
|
| 2019
|
ApoE-associated modulation of neuroprotection from Aβ-mediated neurodegeneration in transgenic Caenorhabditis elegans
2019
|
|
| 2018
|
Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer's and Parkinson's disease models of neurodegeneration.
Human Molecular Genetics.
27:4176-4193.
2018
|
|
| 2018
|
No country for old worms: A systematic review of the application of C. elegans to investigate a bacterial source of environmental neurotoxicity in parkinson’s disease.
Metabolites.
8.
2018
|
|
| 2018
|
Alpha-synuclein inhibits Snx3-retromer-mediated retrograde recycling of iron transporters in S. cerevisiae and C. elegans models of Parkinson's disease.
Human Molecular Genetics.
27:1514-1532.
2018
|
|
| 2018
|
Gene-by-environment interactions that disrupt mitochondrial homeostasis cause neurodegeneration in C. elegans Parkinson's models.
Cell Death and Disease.
9.
2018
|
|
| 2017
|
Genetic and Pharmacological Discovery for Alzheimer's Disease Using Caenorhabditis elegans.
ACS Chemical Neuroscience.
8:2596-2606.
2017
|
|
| 2017
|
NCEH-1 modulates cholesterol metabolism and protects against α-synuclein toxicity in a C. elegans model of Parkinson's disease.
Human Molecular Genetics.
26:3823-3836.
2017
|
|
| 2017
|
Dihydropyrimidine-Thiones and Clioquinol Synergize to Target β-Amyloid Cellular Pathologies through a Metal-Dependent Mechanism.
ACS Chemical Neuroscience.
8:2039-2055.
2017
|
|
| 2017
|
C. elegans as a model system to accelerate discovery for Parkinson disease.
Current Opinion in Genetics and Development.
44:102-109.
2017
|
|
| 2017
|
Meet our editorial board member.
Current Neuropharmacology.
15:195.
2017
|
|
| 2015
|
A bacterial metabolite induces glutathione-tractable proteostatic damage, proteasomal disturbances, and PINK1-dependent autophagy in C. elegans.
Cell Death and Disease.
6.
2015
|
|
| 2015
|
Glutaredoxin deficiency exacerbates neurodegeneration in C. Elegans models of Parkinson's disease.
Human Molecular Genetics.
24:1322-1335.
2015
|
|
| 2014
|
The glycolytic enzyme, GPI, is a functionally conserved modifier of dopaminergic neurodegeneration in Parkinson's models.
Cell Metabolism.
20:145-157.
2014
|
|
| 2014
|
TorsinA rescues ER-associated stress and locomotive defects in C. elegans models of ALS
2014
|
|
| 2014
|
Potentiated Hsp104 variants antagonize diverse proteotoxic misfolding events.
Cell.
156:170-182.
2014
|
|
| 2014
|
Protective Role of DNJ-27/ERdj5 in Caenorhabditis elegans models of human neurodegenerative diseases.
Antioxidants and Redox Signaling.
20:217-235.
2014
|
|
| 2014
|
Mitochondrial dysfunction, oxidative stress, and neurodegeneration elicited by a bacterial metabolite in a C. elegans Parkinson's model.
Cell Death and Disease.
5.
2014
|
|
| 2013
|
Invertebrate models of dystonia.
Current Neuropharmacology.
11:16-29.
2013
|
|
| 2012
|
Identification of novel ATP13A2 interactors and their role in α-synuclein misfolding and toxicity.
Human Molecular Genetics.
21:3785-3794.
2012
|
|
| 2012
|
The early-onset torsion dystonia-associated protein, torsinA, is a homeostatic regulator of endoplasmic reticulum stress response.
Human Molecular Genetics.
21:1201.
2012
|
|
| 2012
|
Different 8-hydroxyquinolines protect models of TDP-43 protein, α-synuclein, and polyglutamine proteotoxicity through distinct mechanisms.
Journal of Biological Chemistry.
287:4107-4120.
2012
|
|
| 2011
|
Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models.
Human Molecular Genetics.
20:3933-3942.
2011
|
|
| 2011
|
Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies.
Cell.
146:37-52.
2011
|
|
| 2010
|
The early-onset torsion dystonia-associated protein, torsinA, displays molecular chaperone activity in vitro.
Cell Stress and Chaperones.
15:605-617.
2010
|
|
| 2010
|
Disinfecting dystonia? Drug discovery using worms identifies an antibiotic as a neuroprotective lead molecule for movement disorders.
Future Neurology.
5:473-476.
2010
|
|
| 2010
|
The early-onset torsion dystonia-associated protein, torsinA, is a homeostatic regulator of endoplasmic reticulum stress response.
Human Molecular Genetics.
19:3502-3515.
2010
|
|
| 2010
|
C. elegans as a model organism to investigate molecular pathways involved with Parkinson's disease.
Developmental Dynamics.
239:1282-1295.
2010
|
|
| 2010
|
Chemical enhancement of torsinA function in cell and animal models of torsion dystonia
2010
|
|
| 2010
|
Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models
2010
|
|
| 2010
|
Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease.
Cell Death and Disease.
1.
2010
|
|
| 2010
|
Low-dose bafilomycin attenuates neuronal cell death associated with autophagy-lysosome pathway dysfunction.
Journal of Neurochemistry.
114:1193-1204.
2010
|
|
| 2009
|
Pharmacogenetic analysis reveals a post-developmental role for Rac GTPases in Caenorhabditis elegans GABAergic neurotransmission
2009
|
|
| 2009
|
The microtubule-associated protein, NUD-1, exhibits chaperone activity in vitro.
Cell Stress and Chaperones.
14:95-103.
2009
|
|
| 2008
|
Traversing a wormhole to combat Parkinson's disease
2008
|
|
| 2008
|
Animal models for drug discovery in dystonia.
Expert Opinion on Drug Discovery.
3:83-97.
2008
|
|
| 2007
|
Ubiquitin conjugating enzymes participate in polyglutamine protein aggregation.
BMC Cell Biology.
8.
2007
|
|
| 2006
|
Genetic interactions among cortical malformation genes that influence susceptibility to convulsions in C. elegans.
Brain Research.
1120:23-34.
2006
|
|
| 2004
|
MEC-2 is recruited to the putative mechanosensory complex in C. elegans touch receptor neurons through its stomatin-like domain.
Current Biology.
14:1888-1896.
2004
|
|
| 2004
|
Epileptic-like convulsions associated with LIS-1 in the cytoskeletal control of neurotransmitter signaling in Caenorhabditis elegans.
Human Molecular Genetics.
13:2043-2059.
2004
|
|
| 2004
|
An animal model to discern torsin function: suppression of protein aggregation in C. elegans.
2004
|
|
| 2004
|
Using Caenorhabditis elegans to probe toxicity of 1-alkyl-3-methylimidazolium chloride based ionic liquids.
Chemical Communications.
4:668-669.
2004
|
|
| 2003
|
Role of NudC, a dynein-associated nuclear movement protein, in mitosis and cytokinesis.
Journal of Cell Science.
116:1991-2003.
2003
|
|
| 2003
|
Suppression of polyglutamine-induced protein aggregation in Caenorhabditis elegans by torsin proteins.
Human Molecular Genetics.
12:307-319.
2003
|
|
| 2001
|
Evolutionarily conserved nuclear migration genes required for early embryonic development in Caenorhabditis elegans
2001
|
|
| 1995
|
Fungal lipopeptide mating pheromones: A model system for the study of protein prenylation.
Microbiological reviews.
59:406-422.
1995
|
|
| 1994
|
Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene.
Antimicrobial Agents and Chemotherapy.
38:648-652.
1994
|
|
| 1994
|
Molecular determinants of bioactivity of the Saccharomyces cerevisiae lipopeptide mating pheromone.
Journal of Biological Chemistry.
269:19817-19825.
1994
|
|
| 1993
|
Identification of a hyperactive mating pheromone of Saccharomyces cerevisiae.
Biochemical and Biophysical Research Communications.
197:1173-1178.
1993
|
|
| 1990
|
Total in vitro maturation of the Saccharomyces cerevisiae a-factor lipopeptide mating pheromone.
Biochemical and Biophysical Research Communications.
172:1310-1316.
1990
|
|
| 1990
|
Purification, properties, and titer of a hemolymph trophic factor in larvae and pupae of Manduca sexta.
Insect biochemistry.
20:65-72.
1990
|
|
| 1989
|
Total synthesis of the lipopeptide a-mating factor ofSaccharomyces cerevisiae.
Biochemical and Biophysical Research Communications.
162:253-257.
1989
|
|
